Exhibit 2.1
EXECUTION VERSION
AGREEMENT AND PLAN OF
MERGER
between
TELEFONAKTIEBOLAGET LM ERICSSON
(publ)
(“Parent”)
MAXWELL ACQUISITION
CORPORATION
(“Purchaser”)
and
REDBACK NETWORKS
INC.
(the “Company”)
dated
Dated as of December 19,
2006
Table of
Contents
TABLE OF
CONTENTS
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
ARTICLE I THE OFFER AND MERGER
|
|
2
|
|
|
|
|
|
Section 1.1
|
|
The
Offer
|
|
2
|
|
Section 1.2
|
|
Company
Actions
|
|
5
|
|
Section 1.3
|
|
Directors
|
|
6
|
|
Section 1.4
|
|
The
Merger
|
|
8
|
|
Section 1.5
|
|
Effective
Time
|
|
8
|
|
Section 1.6
|
|
Closing
|
|
8
|
|
Section 1.7
|
|
Directors and
Officers of the Surviving Corporation
|
|
9
|
|
Section 1.8
|
|
Subsequent
Actions
|
|
9
|
|
Section 1.9
|
|
Stockholders’ Meeting
|
|
9
|
|
Section 1.10
|
|
Merger Without
Meeting of Stockholders
|
|
11
|
|
|
|
|
ARTICLE II CONVERSION OF SECURITIES
|
|
11
|
|
|
|
|
|
Section 2.1
|
|
Conversion of
Capital Stock
|
|
11
|
|
Section 2.2
|
|
Exchange of
Certificates
|
|
12
|
|
Section 2.3
|
|
Dissenting
Shares
|
|
13
|
|
Section 2.4
|
|
Top-Up
Options
|
|
14
|
|
Section 2.5
|
|
Treatment of
Options, Restricted Stock and other Equity Awards
|
|
16
|
|
Section 2.6
|
|
Treatment of
Employee Stock Purchase Plan
|
|
18
|
|
Section 2.7
|
|
Treatment of
Warrants
|
|
18
|
|
|
|
|
ARTICLE III REPRESENTATIONS AND WARRANTIES OF
THE COMPANY
|
|
19
|
|
|
|
|
|
Section 3.1
|
|
Organization
|
|
19
|
|
Section 3.2
|
|
Capitalization
|
|
20
|
|
Section 3.3
|
|
Authorization;
Validity of Agreement; Company Action
|
|
21
|
|
Section 3.4
|
|
Board
Approvals
|
|
22
|
|
Section 3.5
|
|
Consents and
Approvals; No Violations
|
|
22
|
|
Section 3.6
|
|
Company SEC
Documents and Financial Statements
|
|
23
|
|
Section 3.7
|
|
Internal
Controls; Sarbanes-Oxley Act
|
|
24
|
|
Section 3.8
|
|
Absence of
Certain Changes
|
|
25
|
|
Section 3.9
|
|
No Undisclosed
Liabilities
|
|
25
|
|
Section 3.10
|
|
Litigation
|
|
25
|
|
Section 3.11
|
|
Employee
Benefit Plans; ERISA
|
|
26
|
|
Section 3.12
|
|
Taxes
|
|
30
|
|
Section 3.13
|
|
Contracts
|
|
32
|
|
Section 3.14
|
|
Title to
Properties; Encumbrances
|
|
33
|
|
Section 3.15
|
|
Intellectual
Property
|
|
33
|
i
|
|
|
|
|
|
|
Section 3.16
|
|
Labor
Matters
|
|
36
|
|
Section 3.17
|
|
Compliance with
Laws; Permits
|
|
37
|
|
Section 3.18
|
|
Information in
the Proxy Statement
|
|
38
|
|
Section 3.19
|
|
Information in
the Offer Documents and the Schedule 14D-9
|
|
39
|
|
Section 3.20
|
|
Opinion of
Financial Advisor
|
|
39
|
|
Section 3.21
|
|
Insurance
|
|
39
|
|
Section 3.22
|
|
Environmental
Laws and Regulations
|
|
39
|
|
Section 3.23
|
|
Brokers;
Expenses
|
|
40
|
|
Section 3.24
|
|
Takeover
Statutes
|
|
40
|
|
Section 3.25
|
|
Bankruptcy
|
|
40
|
|
|
|
|
ARTICLE IV REPRESENTATIONS AND WARRANTIES OF
PARENT AND PURCHASER
|
|
41
|
|
|
|
|
|
Section 4.1
|
|
Organization
|
|
41
|
|
Section 4.2
|
|
Authorization;
Validity of Agreement; Necessary Action
|
|
41
|
|
Section 4.3
|
|
Consents and
Approvals; No Violations
|
|
42
|
|
Section 4.4
|
|
Litigation
|
|
42
|
|
Section 4.5
|
|
Information in
the Proxy Statement
|
|
42
|
|
Section 4.6
|
|
Information in
the Offer Documents
|
|
42
|
|
Section 4.7
|
|
Ownership of
Company Capital Stock
|
|
43
|
|
Section 4.8
|
|
Sufficient
Funds
|
|
43
|
|
|
|
|
ARTICLE V CONDUCT OF BUSINESS PENDING THE
MERGER
|
|
43
|
|
|
|
|
|
Section 5.1
|
|
Interim
Operations of the Company
|
|
43
|
|
Section 5.2
|
|
No
Solicitation; Unsolicited Proposals
|
|
47
|
|
Section 5.3
|
|
Board
Recommendation
|
|
49
|
|
Section 5.4
|
|
Bankruptcy
Claims
|
|
51
|
|
|
|
|
ARTICLE VI ADDITIONAL AGREEMENTS
|
|
51
|
|
|
|
|
|
Section 6.1
|
|
Notification of
Certain Matters
|
|
51
|
|
Section 6.2
|
|
Access;
Confidentiality
|
|
51
|
|
Section 6.3
|
|
Consents and
Approvals
|
|
52
|
|
Section 6.4
|
|
Publicity
|
|
55
|
|
Section 6.5
|
|
Directors’ and Officers’ Insurance
and Indemnification
|
|
55
|
|
Section 6.6
|
|
State Takeover
Laws
|
|
57
|
|
Section 6.7
|
|
Certain Tax
Matters
|
|
57
|
|
Section 6.8
|
|
Rights
Agreement; Consequences if Rights Triggered
|
|
57
|
|
Section 6.9
|
|
Section
16
|
|
57
|
|
Section 6.10
|
|
Obligations of
Purchaser
|
|
58
|
|
Section 6.11
|
|
Employee
Benefits Matters
|
|
58
|
|
Section 6.12
|
|
Termination of
401(k) Plan
|
|
58
|
|
Section 6.13
|
|
Rule
14d-10(d)
|
|
59
|
ii
|
|
|
|
|
|
|
ARTICLE VII CONDITIONS
|
|
59
|
|
|
|
|
|
Section 7.1
|
|
Conditions to
Each Party’s Obligations to Effect the Merger
|
|
59
|
|
|
|
|
ARTICLE VIII TERMINATION
|
|
60
|
|
|
|
|
|
Section 8.1
|
|
Termination
|
|
60
|
|
Section 8.2
|
|
Effect of
Termination
|
|
61
|
|
|
|
|
ARTICLE IX MISCELLANEOUS
|
|
63
|
|
|
|
|
|
Section 9.1
|
|
Amendment and
Modification; Waiver
|
|
63
|
|
Section 9.2
|
|
Non-survival of
Representations and Warranties
|
|
63
|
|
Section 9.3
|
|
Expenses
|
|
63
|
|
Section 9.4
|
|
Notices
|
|
64
|
|
Section 9.5
|
|
Certain
Definitions
|
|
65
|
|
Section 9.6
|
|
Terms Defined
Elsewhere
|
|
70
|
|
Section 9.7
|
|
Interpretation
|
|
73
|
|
Section 9.8
|
|
Counterparts
|
|
74
|
|
Section 9.9
|
|
Entire
Agreement; No Third-Party Beneficiaries
|
|
74
|
|
Section 9.10
|
|
Severability
|
|
74
|
|
Section 9.11
|
|
Governing Law;
Jurisdiction
|
|
74
|
|
Section 9.12
|
|
Waiver of Jury
Trial
|
|
75
|
|
Section 9.13
|
|
Assignment
|
|
75
|
|
Section 9.14
|
|
Enforcement;
Remedies
|
|
76
|
iii
ANNEXES AND
SCHEDULE
|
|
|
|
|
Annex
I
|
|
Conditions to
the Offer
|
|
Annex
II
|
|
Key
Employees
|
|
Schedule
5.4
|
|
Bankruptcy
Claims
|
EXHIBITS
|
|
|
|
|
Exhibit
A
|
|
Form of
Certificate of Incorporation of the Surviving
Corporation
|
|
Exhibit
B
|
|
Form of Bylaws
of the Surviving Corporation
|
iv
AGREEMENT AND PLAN OF
MERGER
AGREEMENT AND PLAN OF MERGER
(hereinafter referred to as this “ Agreement ”),
dated December 19, 2006, between Telefonaktiebolaget LM
Ericsson (publ), a limited liability company under the Swedish
Companies Act (“ Parent ”), Maxwell Acquisition
Corporation, a Delaware corporation and an indirect wholly-owned
subsidiary of Parent (“ Purchaser ”), and
Redback Networks Inc., a Delaware corporation (the “
Company ”).
WHEREAS, the Board of Directors of,
or authorized committee thereof, each of Parent, Purchaser and the
Company has approved, and deems it advisable and in the best
interests of their respective stockholders to consummate the
acquisition of the Company by Parent upon the terms and subject to
the conditions set forth herein;
WHEREAS, in furtherance thereof and
pursuant to this Agreement, Purchaser has agreed to commence a
tender offer (the “ Offer ”) to purchase all of
the outstanding shares of the Common Stock of the Company,
including the associated Company Rights (such shares of Common
Stock with the associated Company Rights are referred to
collectively as the “ Shares ”), at a price per
Share of US$25.00 (such amount or any different amount per Share
that may be paid pursuant to the Offer being hereinafter referred
to as the “ Offer Price ”), subject to any
withholding of Taxes required by law, net to the seller in
cash;
WHEREAS, following the consummation
of the Offer, upon the terms and subject to the conditions set
forth in this Agreement, Purchaser will be merged with and into the
Company with the Company as the Surviving Corporation (the “
Merger ,” and together with the Offer and the other
transactions contemplated by this Agreement, the “
Transactions ”), in accordance with the General
Corporation Law of the State of Delaware (the “ DGCL
”), whereby each issued and outstanding Share not owned
directly or indirectly by Parent, Purchaser or the Company will be
converted into the right to receive the Offer Price in
cash;
WHEREAS, the Board of Directors of
the Company (the “ Company Board of Directors ”)
has unanimously, on the terms and subject to the conditions set
forth herein, (i) determined that the Transactions
contemplated by this Agreement are in the best interests of its
stockholders, (ii) approved and declared advisable this
Agreement and the Transactions contemplated hereby, including the
Offer and the Merger, and (iii) determined to recommend that
the Company’s stockholders accept the Offer, tender their
Shares to Purchaser and, to the extent applicable, adopt this
Agreement;
WHEREAS, the Board of Directors of,
or authorized committee thereof, Parent and Purchaser have, on the
terms and subject to the conditions set forth herein, unanimously
declared advisable this Agreement and the Transactions contemplated
hereby, including the Offer and the Merger;
WHEREAS, as a condition to and
inducement to Parent’s and Purchaser’s willingness to
enter into this Agreement, simultaneously with the execution of
this Agreement, certain stockholders of the Company are entering
into tender and stockholder support agreements with Parent and
Purchaser (the “ Support Agreements
”);
1
WHEREAS, Parent, Purchaser and the
Company desire to (i) make certain representations and
warranties in connection with the Offer and the Merger,
(ii) make certain covenants and agreements in connection with
the Offer and the Merger, and (iii) prescribe various
conditions to the Offer and the Merger.
NOW, THEREFORE, in consideration of
the mutual covenants and promises contained in this Agreement and
for other good and valuable consideration, the receipt and adequacy
of which are hereby acknowledged, the parties to this Agreement
agree as follows:
ARTICLE I
THE OFFER AND MERGER
Section 1.1 The Offer
.
(a) Provided that this Agreement
shall not have been terminated in accordance with Section 8.1,
as promptly as practicable (and in any event within ten
(10) business days) after the date hereof, Purchaser shall
(and Parent shall cause Purchaser to) commence (within the meaning
of Rule 14d-2 under the Securities Exchange Act of 1934, as
amended, and the rules and regulations promulgated thereunder (the
“ Exchange Act ”)) the Offer to purchase for
cash all Shares at the Offer Price, subject to:
(i) there being validly tendered in
the Offer and not withdrawn prior to any then scheduled Expiration
Date (as defined below) that number of Shares which, together with
the Shares then beneficially owned by Parent or Purchaser (if any),
represents at least a majority of:
(x) all Shares then outstanding,
plus
(y) all Shares issuable upon the
exercise, conversion or exchange of any Company Options, SARs,
RSUs, Warrants, Equity Interests or other rights to acquire Shares
then outstanding that are vested and exercisable, convertible or
exchangeable as of any then scheduled Expiration Date or that would
be vested and exercisable, convertible or exchangeable (including
after giving effect to the acceleration of any vesting or
exercisability, convertibility or exchangeability that may occur as
a result of the Offer) at any time within sixty (60) days
following the then scheduled Expiration Date assuming that the
holder of such Company Options, SARs, RSUs, Warrants, Equity
Interests or other rights satisfies the vesting or exercisability,
convertibility or exchangeability conditions applicable thereto
during such time period, less
(z) the number of Shares issuable
upon the exercise of Company Options then outstanding held by Kevin
A. DeNuccio which are vested and exercisable as of the then
scheduled Expiration Date or that would be vested and exercisable
(including after giving effect to the acceleration of any vesting
or exercisability that may occur as a result of the Offer) at any
time within sixty (60) days following the then scheduled
Expiration Date assuming that Mr. DeNuccio satisfies the
vesting or exercisability conditions applicable thereto during such
time period (the “ Minimum Condition ”);
and
2
(ii) the satisfaction, or waiver by
Parent or Purchaser, of the other conditions and requirements set
forth in Annex I.
(b) The obligation of the Purchaser
to accept for payment and pay for any Shares validly tendered and
not withdrawn pursuant to the Offer shall be subject to the
satisfaction of the Minimum Condition and the satisfaction, or
waiver by Parent or Purchaser, of the other conditions and
requirements set forth in Annex I. Subject to the prior
satisfaction of the Minimum Condition and the satisfaction or
waiver by Parent or Purchaser of the other conditions and
requirements set forth in Annex I, Purchaser shall (and Parent
shall cause Purchaser to) consummate the Offer in accordance with
its terms and accept for payment and pay for all Shares validly
tendered and not withdrawn pursuant to the Offer as promptly as
practicable after Purchaser is legally permitted to do so under
applicable law. The Offer Price payable in respect of each Share
validly tendered and not withdrawn pursuant to the Offer shall be
paid net to the Seller in cash subject to withholding as provide in
Section 2.2(e).
(c) The Offer shall be made by means
of an offer to purchase (the “ Offer to Purchase
”) that contains the terms set forth in this Agreement, the
Minimum Condition and the other conditions and requirements set
forth in Annex I. Parent and Purchaser expressly reserve the right
to increase the Offer Price or to make any other changes in the
terms and conditions of the offer; provided , however
, that unless otherwise provided by this Agreement or as previously
approved by the Company in writing, Purchaser shall not
(i) decrease the Offer Price, (ii) change the form of
consideration payable in the Offer, (iii) reduce the maximum
number of Shares to be purchased in the Offer, (iv) impose
conditions to the Offer that are different than or in addition to
the conditions set forth in Annex I, (v) amend or waive the
Minimum Condition, (vi) amend any of the conditions to the
Offer set forth in Annex I, or (vii) extend the expiration of
the Offer in a manner other than as required by this
Agreement.
(d) Unless extended pursuant to and
in accordance with the terms of this Agreement, the Offer shall
expire at midnight (New York City time) on the date that is twenty
(20) business days (for this purpose calculated in accordance
with Rule 14d-1(g)(3) under the Exchange Act) following the
commencement (within the meaning of Rule 14d-2 under the Exchange
Act) of the Offer (the “ Initial Expiration Date
”) or, in the event the Initial Expiration Date has been
extended pursuant to and in accordance with this Agreement, the
date to which the Offer has been so extended (the Initial
Expiration Date, or such later date to which the Initial Expiration
Date has been extended pursuant to and in accordance with this
Agreement, is referred to as the “ Expiration Date
”).
(e) The Offer shall be extended from
time to time as follows:
(i) Offer Conditions Not
Satisfied . If on or prior to any then scheduled Expiration
Date, all of the conditions to the Offer (including the Minimum
Condition and all other conditions and requirements set forth in
Annex I) shall not have been satisfied,
3
or waived by Parent or Purchaser if
permitted hereunder, Purchaser shall (and Parent shall cause
Purchaser to) extend the Offer for successive periods of ten
(10) business days each in order to permit the satisfaction of
such conditions, or any lesser period ending on April 19, 2007
(the “ Initial Outside Date ”), or on
December 19, 2007 in the event that the HSR Condition and/or
the Governmental Approval Condition shall not have been satisfied,
or waived by Parent and Purchaser if permitted hereunder, by the
Initial Outside Date (the “ Extended Outside Date
”), if any such ten-day extension would otherwise end after
the Initial Outside Date or the Extended Outside Date, as
applicable.
(ii) Required by Applicable Law
or Nasdaq . Purchaser shall extend the Offer for any period or
periods required by applicable law, rule, regulation,
interpretation or position of the SEC (or its staff) or
Nasdaq.
(f) If necessary to obtain
sufficient Shares (without regard to the exercise of the 90% Top-Up
Option) to reach the Short Form Threshold, Purchaser may, in its
sole discretion, provide for a “subsequent offering
period” in accordance with Rule 14d-11 under the Exchange
Act. In the event that more than eighty percent (80%) of the
then outstanding Shares have been validly tendered and not
withdrawn pursuant to the Offer following the Expiration Date,
Purchaser shall (and Parent shall cause Purchaser to) provide for a
“subsequent offering period” in accordance with Rule
14d-11 under the Exchange Act of at least ten (10) business
days immediately following the Expiration Date unless Parent and
Purchaser exercise the 90% Top-Up Option. Subject to the terms and
conditions of this Agreement and the Offer, Purchaser shall (and
Parent shall cause Purchaser to) accept for payment, and pay for,
all Shares that are validly tendered and not withdrawn pursuant to
the Offer during such “subsequent offering period”
promptly after any such Shares are tendered during such
“subsequent offering period.” The Offer Documents will
provide for the possibility of a “subsequent offering
period” in a manner consistent with the terms of this
Section 1.1(f).
(g) Purchaser shall not terminate
the Offer prior to any scheduled Expiration Date without the prior
written consent of the Company except in the event that this
Agreement is terminated pursuant to Section 8.1. In the event
that this Agreement is terminated pursuant to Section 8.1,
Purchaser shall (and Parent shall cause Purchaser to) promptly (and
in any event within twenty four (24) hours of such
termination), irrevocably and unconditionally terminate the
Offer.
(h) As soon as practicable after the
commencement of the Offer (within the meaning of Rule 14d-2 under
the Exchange Act), Parent and Purchaser shall file with the
Securities and Exchange Commission (the “ SEC
”), pursuant to Regulation M-A under the Exchange Act
(“ Regulation M-A ”), a Tender Offer Statement
on Schedule TO with respect to the Offer (together with all
amendments, supplements and exhibits thereto, the “
Schedule TO ”). The Schedule TO shall include, as
exhibits, the Offer to Purchase and a form of letter of transmittal
and summary advertisement (collectively, together with any
amendments and supplements thereto, the “ Offer
Documents ”). Parent and Purchaser agree to take all
steps necessary to cause the Offer Documents to be filed
with
4
the SEC and disseminated to holders of Shares,
in each case as and to the extent required by the Exchange Act.
Parent and Purchaser, on the one hand, and the Company, on the
other hand, agree to promptly correct any information provided by
it for use in the Offer Documents if and to the extent that it
shall have become false or misleading in any material respect or as
otherwise required by applicable law. Parent and Purchaser further
agree to take all steps necessary to cause the Offer Documents, as
so corrected (if applicable), to be filed with the SEC and
disseminated to holders of Shares, in each case as and to the
extent required by the Exchange Act. The Company and its counsel
shall be given a reasonable opportunity to review the Schedule TO
and the Offer Documents before they are filed with the SEC, and
Parent and Purchaser shall give due consideration to all the
reasonable additions, deletions or changes suggested thereto by the
Company and its counsel. In addition, Parent and Purchaser shall
provide the Company and its counsel with copies of any written
comments, and shall inform them of any oral comments, that Parent,
Purchaser or their counsel may receive from time to time from the
SEC or its staff with respect to the Schedule TO or the Offer
Documents promptly after receipt of such comments, and any written
or oral responses thereto. The Company and its counsel shall be
given a reasonable opportunity to review any such written responses
and Parent and Purchaser shall give due consideration to all
reasonable additions, deletions or changes suggested thereto by the
Company and its counsel. If the Offer is terminated or withdrawn by
Purchaser, or this Agreement is terminated prior to the purchase of
Shares in the Offer, Purchaser shall promptly return, and shall
cause any depository, acting on behalf of Purchaser to return, all
tendered Shares to the registered holders thereof.
(i) The Offer Price shall be
adjusted appropriately to reflect the effect of any stock split,
reverse stock split, stock dividend (including any dividend or
distribution of securities convertible into Common Stock), cash
dividend, reorganization, recapitalization, reclassification,
combination, exchange of shares or other like change with respect
to Common Stock occurring on or after the date hereof and prior to
the Effective Time.
Section 1.2 Company Actions
.
(a) Contemporaneous with the filing
of the Schedule TO, the Company shall, in a manner that complies
with Rule 14d-9 under the Exchange Act, file with the SEC a Tender
Offer Solicitation/ Recommendation Statement on Schedule 14D-9 with
respect to the Offer (together with all amendments, supplements and
exhibits thereto, the “ Schedule 14D-9 ” that
shall, subject to the provisions of Section 5.3(c), contain
the Company Recommendation. The Company further agrees to take all
steps necessary to cause the Schedule 14D-9 to be filed with the
SEC and disseminated to holders of Shares, in each case as and to
the extent required by the Exchange Act. The Company, on the one
hand, and Parent and Purchaser, on the other hand, agree to
promptly correct any information provided by it for use in the
Schedule 14D-9 if and to the extent that it shall have become false
or misleading in any material respect or as otherwise required by
applicable law. The Company further agrees to take all steps
necessary to cause the Schedule 14D-9, as so corrected (if
applicable), to be filed with the SEC and disseminated to holders
of Shares, in each case as and to the extent required by
5
the Exchange Act. Parent, Purchaser and their
counsel shall be given a reasonable opportunity to review the
Schedule 14D-9 before it is filed with the SEC and the Company
shall give due consideration to all reasonable additions, deletions
or changes suggested thereto by Parent, Purchaser and their
counsel. In addition, the Company shall provide Parent, Purchaser
and their counsel with copies of any written comments, and shall
inform them of any oral comments, that the Company or its counsel
may receive from time to time from the SEC or its staff with
respect to the Schedule 14D-9 promptly after the Company’s
receipt of such comments, and any written or oral responses
thereto. Parent, Purchaser and their counsel shall be given a
reasonable opportunity to review any such written responses and the
Company shall give due consideration to all reasonable additions,
deletions or changes suggested thereto by Parent, Purchaser and
their counsel.
(b) In connection with the Offer,
the Company shall promptly furnish or cause to be furnished to
Purchaser mailing labels, security position listings and any
available listing or computer files containing the names and
addresses of the record holders of the Shares as of the most recent
practicable date, and shall promptly furnish Purchaser with such
information and assistance (including, but not limited to, lists of
holders of the Shares, updated promptly from time to time upon
Purchaser’s request, and their addresses, mailing labels and
lists of security positions) as Purchaser or its agent may
reasonably request for the purpose of communicating the Offer to
the record and beneficial holders of the Shares. Except for such
steps as are necessary to disseminate the Offer Documents and any
other documents necessary to consummate the Offer, the Merger and
the other Transactions contemplated by this Agreement, Purchaser
shall hold in confidence the information contained in any such
labels, listings and files, shall use such information only in
connection with the Offer and the Merger and, if this Agreement
shall be terminated, shall promptly deliver to the Company all
copies of such information.
Section 1.3 Directors
.
(a) Promptly after Purchaser accepts
for payment and pays for any Shares tendered and not withdrawn
pursuant to the Offer (the “ Appointment Time
”), and at all times thereafter, Purchaser shall be entitled
to elect or designate such number of directors, rounded up to the
next whole number, on the Company Board of Directors as is equal to
the product of the total number of directors on the Company Board
of Directors (giving effect to the directors elected or designated
by Purchaser pursuant to this sentence) multiplied by the
percentage that the aggregate number of Shares beneficially owned
by Parent, Purchaser and any of its affiliates bears to the total
number of Shares then outstanding. The Company shall, upon
Purchaser’s request at any time following the purchase of and
payment for Shares pursuant to the Offer, take such actions,
including but not limited to promptly filling vacancies or newly
created directorships on the Company Board of Directors, promptly
increasing the size of the Company Board of Directors (including by
amending the Bylaws of the Company if necessary so as to increase
the size of the Company Board of Directors) and/or promptly
securing the resignations of such number of its incumbent directors
as are necessary or desirable to enable Purchaser’s designees
to be so elected or designated to the Company Board of Directors,
and shall use its best efforts to cause Purchaser’s designees
to be so elected or designated at such time. The Company shall,
upon Purchaser’s request following the Appointment Time, also
cause
6
Persons elected or designated by Purchaser to
constitute the same percentage (rounded up to the next whole
number) as is on the Company Board of Directors of (i) each
committee of the Company Board of Directors, (ii) each board
of directors (or similar body) of each Company Subsidiary and
(iii) each committee (or similar body) of each such board, in
each case to the extent permitted by applicable law and the
Marketplace Rules of the Nasdaq Global Market (the “
Nasdaq ”). Promptly after the Appointment Time, the
Company shall take all action necessary to elect to be treated as a
“controlled company” as defined by Nasdaq Marketplace
Rule 4350(c) and make all necessary filings and disclosures
associated with such status. The Company’s obligations under
this Section 1.3(a) shall be subject to Section 14(f) of
the Exchange Act and Rule 14f-1 promulgated thereunder. The Company
shall promptly upon execution of this Agreement take all actions
required pursuant to Section 14(f) and Rule 14f-1 in order to
fulfill its obligations under this Section 1.3(a), including
mailing to stockholders (together with the Schedule 14D-9) the
information required by Section 14(f) and Rule 14f-1 as is
necessary to enable Purchaser’s designees to be elected or
designated to the Company Board of Directors. Purchaser shall
supply the Company with information with respect to
Purchaser’s designees and Parent’s and
Purchaser’s respective officers, directors and affiliates to
the extent required by Section 14(f) and Rule 14f-1. The
provisions of this Section 1.3(a) are in addition to and shall
not limit any rights that any of Purchaser, Parent or any of their
respective affiliates may have as a record holder or beneficial
owner of Shares as a matter of applicable law with respect to the
election of directors or otherwise.
(b) In the event that
Purchaser’s designees are elected or designated to the
Company Board of Directors pursuant to Section 1.3(a), then,
until the Effective Time, the Company shall cause the Company Board
of Directors to maintain three (3) directors who are members
of the Company Board of Directors on the date hereof, each of whom
shall be an “independent director” as defined by Rule
4200(a)(15) of the Nasdaq Marketplace Rules and eligible to serve
on the Company’s audit committee under the Exchange Act and
Nasdaq rules and, at least one of whom shall be an “audit
committee financial expert” as defined in Item 401(h) of
Regulation S-K and the instructions thereto (the “
Continuing Directors ”); provided ,
however , that if any Continuing Director is unable to serve
due to death, disability or resignation, the Company shall take all
necessary action (including creating a committee of the Company
Board of Directors) so that the Continuing Director(s) shall be
entitled to elect or designate another Person (or Persons) to fill
such vacancy, and such Person (or Persons) shall be deemed to be a
Continuing Director for purposes of this Agreement. If no
Continuing Director then remains, the other directors shall
designate three (3) Persons to fill such vacancies and such
Persons shall be deemed Continuing Directors for all purposes of
this Agreement. Notwithstanding anything in this Agreement to the
contrary, if Purchaser’s designees constitute a majority of
the Company Board of Directors after the Appointment Time and prior
to the Effective Time, then the affirmative vote of a majority of
the Continuing Directors shall (in addition to the approval rights
of the Company Board of Directors or the stockholders of the
Company as may be required by the Amended and Restated Certificate
of Incorporation of the Company (as amended, the “ Company
Certificate ”), the Amended and Restated Bylaws of the
Company (as amended, the “ Company Bylaws ”, and
together with the Company Certificate, the “ Company
Governing Documents ”) or applicable law) be required
(i) for the Company
7
to amend or terminate this Agreement,
(ii) to exercise or waive any of the Company’s rights,
benefits or remedies hereunder, if such action would materially and
adversely affect the holders of Shares (other than Parent or
Purchaser), (iii) to amend the Company Governing Documents if
such action would materially and adversely affect the holders of
Shares (other than Parent or Purchaser) or (iv) to take any
other action of the Company Board of Directors under or in
connection with this Agreement if such action would materially and
adversely affect the holders of Shares (other than Parent or
Purchaser); provided , however , that if there shall
be no Continuing Directors as a result of such Persons’
deaths, disabilities or refusal to serve, then such actions may be
effected by majority vote of the entire Company Board of
Directors.
Section 1.4 The Merger
.
(a) Subject to the terms and
conditions of this Agreement, and in accordance with the DGCL, at
the Effective Time, the Company and Purchaser shall consummate the
Merger pursuant to which (i) Purchaser shall be merged with
and into the Company and the separate corporate existence of
Purchaser shall thereupon cease, (ii) the Company shall be the
surviving corporation in the Merger and shall continue to be
governed by the DGCL and (iii) the separate corporate
existence of the Company with all its rights, privileges,
immunities, powers and franchises shall continue unaffected by the
Merger. The corporation surviving the Merger is sometimes
hereinafter referred to as the “ Surviving Corporation
.” The Merger shall have the effects set forth in
Section 259 of the DGCL.
(b) Purchaser and the Surviving
Corporation shall take all necessary action such that (i) the
certificate of incorporation of the Surviving Corporation shall be
amended so as to read in its entirety in the form set forth as
Exhibit A hereto until thereafter changed or amended as
provided therein or by applicable law and (ii) the bylaws of
the Surviving Corporation shall be amended so as to read in its
entirety in the form set forth as Exhibit B until thereafter
changed or amended as provided therein or by applicable
law.
Section 1.5 Effective Time .
Parent, Purchaser and the Company shall cause an appropriate
certificate of merger or other appropriate documents (the “
Certificate of Merger ”) to be executed and filed on
the Closing Date (or on such other date as Parent and the Company
may agree) with the Secretary of State of the State of Delaware in
accordance with the relevant provisions of the DGCL and shall make
all other filings or recordings required under the DGCL. The Merger
shall become effective at the time such Certificate of Merger have
been duly filed with the Secretary of State of the State of
Delaware or such date and time as is agreed upon by the parties and
specified in the Certificate of Merger, such date and time
hereinafter referred to as the “ Effective Time
.”
Section 1.6 Closing . The
closing of the Merger (the “ Closing ”) will
take place at 10:00 a.m., California time, on a date to be
specified by the parties, such date to be no later than the second
business day after satisfaction or waiver of all of the conditions
set forth in Article VII (the “ Closing Date ”),
at the offices of Latham & Watkins LLP, 140 Scott Drive ,
Menlo Park, California unless another date or place is agreed to in
writing by the parties hereto.
8
Section 1.7 Directors and
Officers of the Surviving Corporation . The directors of
Purchaser immediately prior to the Effective Time shall, from and
after the Effective Time, be appointed as the directors of the
Surviving Corporation, and the officers of the Company immediately
prior to the Effective Time, from and after the Effective Time,
shall continue as the officers of the Surviving Corporation, in
each case until their respective successors shall have been duly
elected, designated or qualified, or until their earlier death,
resignation or removal in accordance with the Surviving
Corporation’s certificate of incorporation and
bylaws.
Section 1.8 Subsequent
Actions . If at any time after the Effective Time the Surviving
Corporation shall determine, in its sole discretion, or shall be
advised, that any deeds, bills of sale, instruments of conveyance,
assignments, assurances or any other actions or things are
necessary or desirable to vest, perfect or confirm of record or
otherwise in the Surviving Corporation its right, title or interest
in, to or under any of the rights, properties or assets of either
of the Company or Purchaser acquired or to be acquired by the
Surviving Corporation as a result of, or in connection with, the
Merger or otherwise to carry out this Agreement, then the officers
and directors of the Surviving Corporation shall be authorized to
execute and deliver, in the name and on behalf of either the
Company or Purchaser, all such deeds, bills of sale, instruments of
conveyance, assignments and assurances and to take and do, in the
name and on behalf of each of such corporations or otherwise, all
such other actions and things as may be necessary or desirable to
vest, perfect or confirm any and all right, title or interest in,
to and under such rights, properties or assets in the Surviving
Corporation or otherwise to carry out this Agreement.
Section 1.9 Stockholders’
Meeting . If approval of the stockholders of the Company is
required under DGCL in order to consummate the Merger:
(a) As promptly as practicable
following the Appointment Time and the expiration of any
“subsequent offering period” provided by Purchaser
pursuant to and in accordance with this Agreement, if applicable,
the Company shall prepare and file as promptly as practicable with
the SEC a proxy or information statement for the Special Meeting
(together with any amendments thereof or supplements thereto and
any other required proxy materials, the “ Proxy
Statement ”) relating to the Merger and this Agreement;
provided , that Parent, Purchaser and their counsel shall be
given a reasonable opportunity to review the Proxy Statement before
it is filed with the SEC and the Company shall give due
consideration to all reasonable additions, deletions or changes
suggested thereto by Parent, Purchaser and their counsel with the
intention that the Proxy Statement be in a form ready to print and
mail to the stockholders of the Company as promptly as practicable
following the Appointment Time and the expiration of any
“subsequent offering period” provided by Purchaser
pursuant to and in accordance with this Agreement, if applicable.
The Company shall include
9
in the Proxy Statement the recommendation of the
Company Board of Directors that stockholders of the Company vote in
favor of the adoption of this Agreement in accordance with the
DGCL. The Company shall use its reasonable best efforts to obtain
and furnish the information required to be included by the SEC in
the Proxy Statement and, after consultation with Purchaser, respond
promptly to any comments made by the SEC with respect to the Proxy
Statement. The Company shall provide Parent, Purchaser and their
counsel with copies of any written comments, and shall inform them
of any oral comments, that the Company or its counsel may receive
from time to time from the SEC or its staff with respect to the
Proxy Statement promptly after the Company’s receipt of such
comments, and any written or oral responses thereto. Parent,
Purchaser and their counsel shall be given a reasonable opportunity
to review any such written responses and the Company shall give due
consideration to all reasonable additions, deletions or changes
suggested thereto by Parent, Purchaser and their counsel. The
Company, on the one hand, and Parent and Purchaser, on the other
hand, agree to promptly correct any information provided by it for
use in the Proxy Statement if and to the extent that it shall have
become false or misleading in any material respect or as otherwise
required by applicable law and, the Company further agrees to cause
the Proxy Statement, as so corrected (if applicable), to be filed
with the SEC and, if any such correction is made following the
mailing of the Proxy Statement as provided in
Section 1.9(b)(ii), mailed to holders of Shares, in each case
as and to the extent required by the Exchange Act or the SEC (or
its staff).
(b) The Company, acting through the
Company Board of Directors, shall, in accordance with and subject
to the requirements of applicable law:
(i) (A) as promptly as practicable
following the Appointment Time and the expiration of any
“subsequent offering period” provided by Purchaser
pursuant to and in accordance with this Agreement, if applicable,
duly set a record date for, call and give notice of a special
meeting of its stockholders (the “ Special Meeting
”) for the purpose of considering and taking action upon this
Agreement (with the record date and meeting date set in
consultation with Purchaser), and (B) as promptly as
practicable following the Appointment Time and the expiration of
any “subsequent offering period” provided by Purchaser
pursuant to and in accordance with this Agreement, if applicable,
convene and hold the Special Meeting;
(ii) cause the definitive Proxy
Statement to be mailed to its stockholders; and
(iii) use its reasonable best
efforts to (A) solicit from its stockholders proxies in favor
of the adoption of this Agreement and (B) secure any approval
of stockholders of the Company that is required by the DGCL and any
other applicable law to effect the Merger.
(c) At the Special Meeting or any
postponement or adjournment thereof, Parent shall vote, or cause to
be voted, all of the Shares then owned by it, Purchaser or any of
their other subsidiaries and affiliates in favor of the adoption of
this Agreement and to deliver or provide, in its capacity as a
stockholder of the Company, any other approvals that are required
by the DGCL and any other applicable law to effect the
Merger.
10
Section 1.10 Merger Without
Meeting of Stockholders . Notwithstanding the terms of
Section 1.9, in the event that Parent, Purchaser and their
respective subsidiaries and affiliates shall hold, in the
aggregate, at least ninety percent (90%) of the outstanding
shares of each class of capital stock of the Company entitled to
vote on the adoption of this Agreement under the DGCL (the “
Short Form Threshold ”), following the Appointment
Time and the expiration of any “subsequent offering
period” provided by Purchaser pursuant to and in accordance
with this Agreement, if applicable, and the exercise of the 90%
Top-Up Option, if applicable, Parent shall cause the Merger to
become effective as promptly as practicable, without a meeting of
stockholders of the Company, in accordance with Section 253 of
the DGCL.
ARTICLE II
CONVERSION OF SECURITIES
Section 2.1 Conversion of Capital
Stock . At the Effective Time, by virtue of the Merger and
without any action on the part of the holders of any securities of
the Company or common stock, par value $0.0001 per share, of
Purchaser (the “ Purchaser Common Stock
”):
(a) Purchaser Common Stock .
Each issued and outstanding share of Purchaser Common Stock shall
be converted into and become one fully paid and nonassessable share
of common stock, par value $0.0001 per share, of the Surviving
Corporation.
(b) Cancellation of Treasury
Stock and Parent-Owned Stock . All Shares that are owned by the
Company and any Shares owned by Parent, Purchaser or any of their
respective subsidiaries or affiliates shall be cancelled and shall
cease to exist, and no consideration shall be delivered in exchange
therefor.
(c) Conversion of Common
Stock . Each issued and outstanding Share (other than Shares to
be cancelled in accordance with Section 2.1(b) and other than
Dissenting Shares) shall be converted into the right to receive the
Offer Price, payable to the holder thereof in cash, without
interest (the “ Merger Consideration ”). From
and after the Effective Time, all such Shares shall no longer be
outstanding and shall automatically be cancelled and shall cease to
exist, and each holder of a certificate representing any such
Shares shall cease to have any rights with respect thereto, except
the right to receive the Merger Consideration therefor upon the
surrender of such certificate in accordance with Section 2.2,
without interest thereon.
(d) Adjustment to Merger
Consideration . The Merger Consideration shall be adjusted
appropriately to reflect the effect of any stock split, reverse
stock split, stock dividend (including any dividend or distribution
of securities convertible into Common Stock), cash dividend,
reorganization, recapitalization, reclassification, combination,
exchange of shares or other like change with respect to Common
Stock occurring on or after the date hereof and prior to the
Effective Time.
11
Section 2.2 Exchange of
Certificates .
(a) Paying Agent . Purchaser
shall designate a bank or trust company to act as the payment agent
in connection with the Merger (the “ Paying Agent
”). Prior to the Effective Time, Parent or Purchaser shall
deposit, or cause to be deposited, with the Paying Agent the
aggregate Merger Consideration. Such funds shall be invested by the
Paying Agent as directed by Parent, in its sole discretion, pending
payment thereof by the Paying Agent to the holders of the Shares.
Earnings from such investments shall be the sole and exclusive
property of Parent, and no part of such earnings shall accrue to
the benefit of holders of Shares.
(b) Exchange Procedures .
Promptly after the Effective Time, the Paying Agent shall mail to
each holder of record of a certificate or certificates which
immediately prior to the Effective Time represented outstanding
Shares (the “ Certificates ”) and whose Shares
were converted pursuant to Section 2.1 into the right to
receive the Merger Consideration (i) a letter of transmittal
(which shall specify that delivery shall be effected, and risk of
loss and title to the Certificates shall pass, only upon delivery
of the Certificates to the Paying Agent and shall be in such form
and have such other provisions as Parent may reasonably specify)
and (ii) instructions for effecting the surrender of the
Certificates in exchange for payment of the Merger Consideration.
Upon surrender of a Certificate for cancellation to the Paying
Agent or to such other agent or agents as may be appointed by
Parent, together with such letter of transmittal, duly executed,
the holder of such Certificate shall be entitled to receive in
exchange therefor the Merger Consideration for each Share formerly
represented by such Certificate and the Certificate so surrendered
shall forthwith be cancelled. If payment of the Merger
Consideration is to be made to a Person other than the Person in
whose name the surrendered Certificate is registered, it shall be a
condition precedent of payment that (x) the Certificate so
surrendered shall be properly endorsed or shall be otherwise in
proper form for transfer and (y) the Person requesting such
payment shall have paid any transfer and other similar taxes
required by reason of the payment of the Merger Consideration to a
Person other than the registered holder of the Certificate
surrendered or shall have established to the satisfaction of the
Surviving Corporation that such tax either has been paid or is not
required to be paid. Until surrendered as contemplated by this
Section 2.2, each Certificate shall be deemed at any time
after the Effective Time to represent only the right to receive the
Merger Consideration in cash as contemplated by this
Section 2.2, without interest thereon.
(c) Transfer Books; No Further
Ownership Rights in Shares . At the Effective Time, the stock
transfer books of the Company shall be closed and thereafter there
shall be no further registration of transfers of Shares on the
records of the Company. From and after the Effective Time, the
holders of Certificates outstanding immediately prior to the
Effective Time shall cease to have any rights with respect to such
Shares except as otherwise provided for herein or by applicable
law. If, after the Effective Time, Certificates are presented to
the Surviving Corporation for any reason, they shall be cancelled
and exchanged as provided in this Article II.
12
(d) Termination of Fund; No
Liability . At any time following six months after the
Effective Time, the Surviving Corporation shall be entitled to
require the Paying Agent to deliver to it any funds (including any
interest received with respect thereto) made available to the
Paying Agent and not disbursed (or for which disbursement is
pending subject only to the Paying Agent’s routine
administrative procedures) to holders of Certificates, and
thereafter such holders shall be entitled to look only to the
Surviving Corporation (subject to abandoned property, escheat or
other similar laws) only as general creditors thereof with respect
to the Merger Consideration payable upon due surrender of their
Certificates, without any interest thereon. Notwithstanding the
foregoing, neither the Surviving Corporation nor the Paying Agent
shall be liable to any holder of a Certificate for Merger
Consideration delivered to a public official pursuant to any
applicable abandoned property, escheat or similar law.
(e) Withholding Rights .
Parent, Purchaser, the Surviving Corporation and the Paying Agent,
as the case may be, shall be entitled to deduct and withhold from
the relevant Merger Consideration or Offer Price otherwise payable
pursuant to this Agreement to any holder of Shares such amounts
that Parent, Purchaser, the Surviving Corporation or the Paying
Agent is required to deduct and withhold with respect to the making
of such payment under the Internal Revenue Code of 1986, as amended
(the “ Code ”), the rules and regulations
promulgated thereunder or any provision of applicable state, local
or foreign law. To the extent that amounts are so withheld by
Parent, Purchaser, the Surviving Corporation or the Paying Agent,
such amounts shall be treated for all purposes of this Agreement as
having been paid to the holder of Shares in respect of which such
deduction and withholding was made by Parent, Purchaser, the
Surviving Corporation or the Paying Agent.
(f) Lost, Stolen or Destroyed
Certificates . In the event that any Certificates shall have
been lost, stolen or destroyed, the Paying Agent shall issue in
exchange for such lost, stolen or destroyed Certificates, upon the
making of an affidavit of that fact by the holder thereof, the
Merger Consideration payable in respect thereof pursuant to
Section 2.1 hereof; provided , however , that
Parent may, in its discretion and as a condition precedent to the
payment of such Merger Consideration, require the owners of such
lost, stolen or destroyed Certificates to deliver a bond in such
sum as it may reasonably direct as indemnity against any claim that
may be made against Parent, the Surviving Corporation or the Paying
Agent with respect to the Certificates alleged to have been lost,
stolen or destroyed.
Section 2.3 Dissenting Shares
.
(a) Notwithstanding anything in this
Agreement to the contrary, Shares outstanding immediately prior to
the Effective Time and held by a holder who is entitled to demand
and properly demands appraisal of such Shares (“
Dissenting Shares ”) pursuant to, and who complies in
all respects with, Section 262 of the DGCL (the “
Appraisal Rights ”) shall be entitled to payment of
the fair value of such Dissenting Shares in accordance with the
Appraisal Rights; provided , however , that if any
such holder shall fail to perfect or
13
otherwise shall waive, withdraw or lose the
right to dissent under the Appraisal Rights, then the right of such
holder to be paid the fair value of such holder’s Dissenting
Shares shall cease and such Dissenting Shares shall be deemed to
have been converted as of the Effective Time into, and to have
become exchangeable solely for the right to receive the Merger
Consideration.
(b) The Company shall serve prompt
notice to Purchaser of any demands received by the Company for
dissenter’s rights of any Shares, and Purchaser shall have
the right to participate in all negotiations and proceedings with
respect to such demands. Prior to the Effective Time, the Company
shall not, without the prior written consent of Purchaser, make any
payment with respect to, or settle or compromise or offer to settle
or compromise, any such demand, or agree to do any of the
foregoing.
Section 2.4 Top-Up Options
.
(a) 90% Top-Up Option
.
(i) The Company hereby grants to
Purchaser an irrevocable option (the “ 90% Top-Up
Option ”), exercisable only upon the terms and subject to
the conditions set forth herein, to purchase with a promissory
note, bearing simple interest at 6% per annum, and due 30 days
after the purchase (a “ Promissory Note ”), at a
price per share equal to the Offer Price, that number of shares of
Common Stock (the “ 90% Top-Up Option Shares ”)
equal to the lesser of (x) the lowest number of shares of
Common Stock that, when added to the number of shares of Common
Stock owned by Parent, Purchaser and their respective subsidiaries
and affiliates at the time of such exercise, shall constitute ten
thousand (10,000) shares more than 90% of the shares of Common
Stock then outstanding (after giving effect to the issuance of the
90% Top-Up Option Shares) and (y) an aggregate number of
shares of Common Stock that is equal to 19.9% of the shares of
Common Stock issued and outstanding as of the date hereof;
provided , however , that the 90% Top-Up Option shall
not be exercisable unless, immediately after such exercise and the
issuance of shares of Common Stock pursuant thereto, the Short Form
Threshold would be reached (assuming the issuance of the 90% Top-Up
Option Shares); and provided , further , that in no
event shall the 90% Top-Up Option be exercisable for a number of
shares of Common stock in excess of the Company’s total
authorized and unissued shares of Common Stock.
(ii) Provided that no applicable
law, rule, regulation, order, injunction or other legal impediment
shall prohibit the exercise of the 90% Top-Up Option or the
issuance of the 90% Top-Up Option Shares pursuant thereto, or
otherwise make such exercise or issuance illegal, Purchaser may
exercise the 90% Top-Up Option, in whole but not in part, at any
one time after the Appointment Time and prior to the earlier to
occur of (i) the Effective Time and (ii) the termination
of this Agreement pursuant to Section 8.1.
14
(iii) In the event Purchaser wishes
to exercise the 90% Top-Up Option, Purchaser shall send to the
Company a written notice (a “ 90% Top-Up Exercise
Notice ,” the date of which notice is referred to herein
as the “ 90% Top-Up Notice Date ”) specifying
the denominations of the certificate or certificates evidencing the
90% Top-Up Option Shares which the Purchaser wishes to receive, and
the place, time and date for the closing of the purchase and sale
pursuant to the 90% Top-Up Option (the “ 90% Top-Up
Closing ”). The Company shall, promptly after receipt of
the 90% Top-Up Exercise Notice, deliver a written notice to the
Purchaser confirming the number of 90% Top-Up Option Shares and the
aggregate purchase price therefore (the “ 90% Top-Up
Notice Receipt ”). At the 90% Top-Up Closing, Purchaser
shall pay the Company the aggregate price required to be paid for
the 90% Top-Up Option Shares, by delivery of a Promissory Note in
an aggregate principal amount equal to the amount specified in the
90% Top-Up Notice Receipt, and the Company shall cause to be issued
to Purchaser a certificate or certificates representing the 90%
Top-Up Option Shares. Such certificates may include any legends
that are required by federal or state securities laws.
(b) 50% Top-Up Option.
(i) In order to offset the dilutive
impact of the issuance of Shares pursuant to the exercise,
conversion or exchange of any Company Options, SARs, RSUs,
Warrants, Equity Interests or other rights to acquire Shares
following the Appointment Time, the Company hereby grants to
Purchaser an irrevocable option (the “ 50% Top-Up
Option ”), exercisable only upon the terms and subject to
the conditions set forth herein, to purchase with a Promissory
Note, at a price per share equal to the Offer Price, that number of
shares of Common Stock (the “ 50% Top-Up Option Shares
”) equal to the lesser of (x) the lowest number of
shares of Common Stock that, when added to the number of shares of
Common Stock owned by Parent, Purchaser and their respective
subsidiaries and affiliates at the time of such exercise, shall
constitute ten thousand (10,000) shares more than 50% of the
shares of Common Stock then outstanding (after giving effect to the
issuance of the 50% Top-Up Option Shares) and (y) an aggregate
number of shares of Common Stock that is equal to 19.9% of the
shares of Common Stock issued and outstanding as of the date
hereof; provided , however , that the 50% Top-Up
Option shall not be exercisable unless, immediately after such
exercise and the issuance of shares of Common Stock pursuant
thereto, Purchaser would own more than 50% of the Shares then
outstanding (assuming the issuance of the 50% Top-Up Option
Shares); and provided, further , that in no event shall the
50% Top-Up Option be exercisable for a number of shares of Common
stock in excess of the Company’s total authorized and
unissued shares of Common Stock.
(ii) Provided that no applicable
law, rule, regulation, order, injunction or other legal impediment
shall prohibit the exercise of the 50% Top-Up Option or the
issuance of the 50% Top-Up Option Shares pursuant thereto, or
otherwise make such exercise or issuance illegal, Purchaser may
exercise the 50% Top-Up Option, in whole but not in part, at any
one time after the Appointment Time and prior to the earlier to
occur of (i) the record date for the Special Meeting, and
(ii) the termination of this Agreement pursuant to
Section 8.1.
15
(iii) In the event Purchaser wishes
to exercise the 50% Top-Up Option, Purchaser shall send to the
Company a written notice (a “5 0% Top-Up Exercise
Notice ,” the date of which notice is referred to herein
as the “5 0% Top-Up Notice Date ”) specifying
the denominations of the certificate or certificates evidencing the
50% Top-Up Option Shares which the Purchaser wishes to receive, and
the place, time and date for the closing of the purchase and sale
pursuant to the 50% Top-Up Option (the “5 0% Top-Up
Closing ”). The Company shall, promptly after receipt of
the 50% Top-Up Exercise Notice, deliver a written notice to the
Purchaser confirming the number of 50% Top-Up Option Shares and the
aggregate purchase price therefore (the “5 0% Top-Up
Notice Receipt ”). At the 50% Top-Up Closing, Purchaser
shall pay the Company the aggregate price required to be paid for
the 50% Top-Up Option Shares by delivery of a Promissory Note in an
aggregate principal amount equal to the aggregate purchase price
specified in the 50% Top-Up Notice Receipt, and the Company shall
cause to be issued to Purchaser a certificate or certificates
representing the 50% Top-Up Option Shares. Such certificates may
include any legends that are required by federal or state
securities laws.
Section 2.5 Treatment of Options,
Restricted Stock and other Equity Awards .
(a) At the Effective Time, each
option, or portion thereof, to purchase Shares granted pursuant to
the Company Stock Plans (“ Company Options ”) or
stock appreciation right, or portion thereof, whether settled in
cash or Shares (“ SAR ”), in each case granted
pursuant to the Company Stock Plans, that is outstanding and vested
immediately prior to the Effective Time, shall be deemed exercised
and automatically converted into the right to receive an amount in
cash equal to the product obtained by multiplying (x) the
aggregate number of Shares for which such Company Option or SAR was
vested and exercisable immediately prior to the Effective Time and
(y) the excess, if any, of the Merger Consideration less the
per Share exercise price of such Company Option or SAR (the “
Option Consideration ”) after which it shall be
cancelled and extinguished.
(b) At the Effective Time, each
Company Option and SAR that was outstanding and unvested
immediately prior to the Effective Time shall be assumed by the
Parent and converted into the right to receive the Option
Consideration, provided that the Company Option or SAR shall be
subject to the same vesting arrangements that were applicable to
such Company Option or SAR immediately prior to the Effective Time
and Parent’s obligation to pay the Option Consideration will
only become payable to the extent that such vesting requirements
are satisfied. For each Share subject to a Company Option or SAR
which would have vested after the Effective Time under the vesting
schedule applicable to such Company Option or SAR immediately prior
to the Effective Time, the holder thereof shall be entitled to a
cash payment equal to the Option Consideration, and Parent shall
pay the holder thereof the Option Consideration as soon as
administratively practicable after the day on which such Share
would have vested.
16
(c) At the Effective Time, the
Merger Consideration payable with respect to each unvested Share
subject to restrictions and forfeiture granted pursuant to the
Company Stock Plans (“ Restricted Stock ”) shall
be subject to the same restrictions and vesting arrangements that
were applicable to such unvested Restricted Stock immediately prior
to the Effective Time. Therefore, cash otherwise payable pursuant
to Section 2.1 in exchange for the Restricted Stock issued and
outstanding immediately prior to the Effective Time (“
Unvested Cash ”) shall not automatically be payable by
Parent at the Effective Time, and shall instead become payable by
Parent on the date that such Shares of Restricted Stock would have
become vested under the vesting schedule in place for such shares
immediately prior to or at the Effective Time (subject to the
restrictions and other terms of such vesting schedule). Parent
shall make all such required payments to holders of Unvested Cash
as soon as administratively practicable after the day on which such
Unvested Cash would have become vested under the original vesting
schedule. All outstanding rights to repurchase Restricted Stock
that the Company may hold or similar restrictions in the
Company’s favor immediately prior to the Effective Time (all
such rights, the “ Repurchase Rights ”) shall be
assigned to Parent in the Merger and shall thereafter be
exercisable by Parent upon the same terms and subject to the same
conditions that were in effect immediately prior to the Effective
Time, except that Repurchase Rights may be exercised by Parent
retaining the Unvested Cash into which such Restricted Stock has
been converted, and paying to the former holder thereof the
repurchase price in effect for each such Share subject to that
Repurchase Right immediately prior to the Effective
Time.
(d) At the Effective Time, each
Share subject to a Restricted Stock Unit granted pursuant to the
Company Stock Plans (“ RSU ”) that is
outstanding immediately prior to the Effective Time will be assumed
by the Parent and converted into the potential right to receive a
cash payment equal to the Merger Consideration (the “ RSU
Consideration ”); provided, however, that the RSU shall
be subject to the same vesting arrangements that were applicable
immediately prior to the Effective Time and payment of the RSU
Consideration with respect to a Share subject to an RSU will only
become payable by the Parent to the extent that such vesting
requirements are satisfied. For each Share subject to an RSU which
would have vested after the Effective Time, the holder thereof
shall be entitled to a cash payment equal to the RSU Consideration,
and Parent shall pay the holder thereof the RSU Consideration as
soon as administratively practicable after the day on which such
Share subject to the RSU would have vested.
(e) The Company shall take all
necessary actions, including obtaining any required consents from
holders of outstanding Company Options, SARs, Restricted Stock and
RSUs necessary to effect the transactions described in Sections
2.5(a)-(d) above pursuant to the terms of the applicable
Company Stock Plans and agreements evidencing the Company Options,
SARs Restricted Stock and RSUs. All amounts payable pursuant to
Sections 2.5(a)-(d) shall be paid without interest, and no
Unvested Cash or RSU Consideration or rights to receive any
payments pursuant to Section 2.5(c) and (d) may be
pledged, encumbered, sold, assigned or transferred (including any
transfer by operation of law), by any Person, other than Parent, or
be taken or reached by any legal or
17
equitable process in satisfaction of any
liability of such Person, prior to the distribution to such Person
of such Unvested Cash or RSU Consideration or payment pursuant to
Section 2.5(c) and (d), in accordance with this Agreement. Any
payments made pursuant to this Section 2.5 shall be net of all
applicable withholding taxes that Parent, Purchaser, the Surviving
Corporation and the Paying Agent, as the case may be, shall be
required to deduct and withhold from the relevant Option
Consideration, Unvested Cash, RSU Consideration, or Merger
Consideration under the Code, the rules and regulations promulgated
thereunder or any provision of applicable state, local or foreign
law. To the extent that amounts are so withheld by Parent,
Purchaser, the Surviving Corporation or the Paying Agent, such
amounts shall be treated for all purposes of this Agreement as
having been paid to the holder of Shares in respect of which such
deduction and withholding was made by Parent, Purchaser, the
Surviving Corporation or the Paying Agent.
Section 2.6 Treatment of Employee
Stock Purchase Plan . Each outstanding purchase right (each, a
“ Purchase Right ”) under the Company’s
1999 Employee Stock Purchase Plan (the “ ESPP ”)
shall be cancelled immediately prior to the Effective Time and
converted into the right to receive at the Effective Time from
Parent, an amount (subject to any withholding tax required by
applicable law) in cash equal to the product obtained by
multiplying (x) the number of Shares issuable to the holder of
such Purchase Right had such Purchase Right been exercised
immediately prior to the Effective Time and (y) the amount by
which the Merger Consideration exceeds the purchase price under
such Purchase Right. Within five (5) days following the
Effective Time, Parent shall cause the Company to return to
participants their respective accumulated payroll contributions not
applied to the purchase of Shares under the ESPP, if
any.
Section 2.7 Treatment of
Warrants . At the Effective Time, each warrant to purchase
Shares (the “ Warrants ”) that is issued and
outstanding immediately prior to the Effective Time and not
terminated pursuant to its terms shall be assumed by Parent and
converted into the right to receive cash equal to the product
obtained by multiplying (x) the aggregate number of Shares for
which such Warrant was exercisable immediately prior to the
Effective Time and (y) the excess, if any, of the Merger
Consideration less the per Share exercise price of such Warrant
(the “ Warrant Consideration ”). The Company
shall take all necessary actions, including obtaining any required
consents from holders of outstanding Warrants necessary to effect
such assumption pursuant to the terms of the applicable Warrant.
Any payments made pursuant to this Section 2.7 shall be net of
all applicable withholding taxes that Parent, Purchaser, the
Surviving Corporation and the Paying Agent, as the case may be,
shall be required to deduct and withhold from the Warrant
Consideration under the Code, the rules and regulations promulgated
thereunder or any provision of applicable state, local or foreign
law. To the extent that amounts are so withheld by Parent,
Purchaser, the Surviving Corporation or the Paying Agent, such
amounts shall be treated for all purposes of this Agreement as
having been paid to the holder of Warrants in respect of which such
deduction and withholding was made by Parent, Purchaser, the
Surviving Corporation or the Paying Agent.
18
ARTICLE III
REPRESENTATIONS AND
WARRANTIES OF THE COMPANY
Except as set forth in the
Company’s disclosure schedule delivered to Parent immediately
prior to the execution of this Agreement (the “ Company
Disclosure Schedule ”), the Company represents and
warrants to Parent and Purchaser as set forth below. Each
disclosure set forth in the Company Disclosure Schedule is
identified by reference to, or has been grouped under a heading
referring to, a specific section of this Agreement and disclosure
made pursuant to any section thereof shall be deemed to be
disclosed on each of the other sections of the Company Disclosure
Schedule to the extent the applicability of the disclosure to such
other section is reasonably apparent from the disclosure
made.
Section 3.1 Organization .
(a) The Company and each of the Company Subsidiaries is a
corporation or other legal entity duly organized, validly existing
and in good standing (with respect to jurisdictions which recognize
such concept) under the laws of the jurisdiction in which it is
organized and has the requisite corporate or other power, as the
case may be, and authority to conduct its business as now being
conducted, except, as to Company Subsidiaries, for those
jurisdictions where the failure to be so organized, existing or in
good standing would not reasonably be expected to have,
individually or in the aggregate, a Company Material Adverse
Effect. The Company and each of the Company Subsidiaries is duly
qualified or licensed to do business and is in good standing (with
respect to jurisdictions which recognize such concept) in each
jurisdiction in which the nature of its business or the ownership,
leasing or operation of its properties makes such qualification or
licensing necessary, except for those jurisdictions where the
failure to be so qualified or licensed or to be in good standing
would not reasonably be expected to have, individually or in the
aggregate, a Company Material Adverse Effect. The Company has
delivered to or made available to Parent and Purchaser prior to the
execution of this Agreement true and complete copies of any
amendments to the Company Governing Documents not filed as of the
date hereof with the SEC. The Company is in compliance with the
terms of the Company Governing Documents.
(b) Subsidiaries . Exhibit 21
to the Company’s Annual Report on Form 10-K for the fiscal
year ended December 31, 2005, includes all the Company
Subsidiaries that, as of the date of this Agreement, are “
Significant Subsidiaries ” (as defined in Rule 1-02 of
Regulation S-X of the SEC). All outstanding shares of capital stock
of, or other Equity Interests in, each such Significant Subsidiary
have been validly issued and are fully paid and nonassessable and
are owned directly or indirectly by the Company, free and clear of
any Liens, other than Permitted Liens. Other than the Company
Subsidiaries, the Company does not directly or indirectly
beneficially own any Equity Interests in any other Person except
for non-controlling investments made in the ordinary course of
business in entities which are not individually or in the aggregate
material to the Company and the Company Subsidiaries as a
whole.
19
Section 3.2 Capitalization .
(a) The authorized capital stock of the Company consists of
(i) 750,001,200 shares of common stock, par value $0.0001 per
share (the “ Common Stock ”),
(ii) 10,000,000 shares of preferred stock, par value $0.0001
per share (the “ Preferred Stock ”), of which
250,000 shares has been designated Series A Junior Participating
Preferred Stock, par value $0.0001 per share (the “ Junior
Preferred Stock ” and reserved for issuance in connection
with the rights (the “ Company Rights ”) issued
pursuant to the Rights Agreement dated as of June 12, 2001 (as
amended from time to time, the “ Company Rights
Agreement ”) between the Company and U.S. Stock Transfer
Corporation, as Rights Agent. As of December 15, 2006,
(A) 69,908,406 shares of Common Stock were issued and
outstanding, (B) no shares of Preferred Stock were issued and
outstanding, (C) no shares of Junior Preferred Stock were
issued and outstanding, (D) no shares of Common Stock were
issued and held in the treasury of the Company or otherwise owned
by the Company, (E) 7,592,036 shares of Common Stock were
issuable (and such number was reserved for issuance) upon exercise
of Warrants, and (F) 20,477,738 shares of Common Stock were
reserved for issuance pursuant to the Company Stock Plans of which
13,551,160 shares of Common Stock were subject to outstanding
Company Options, SARs and RSUs (collectively, the “
Company Stock Rights ”) and Restricted Stock. All of
the outstanding shares of the Company’s capital stock are,
and all Shares which may be issued pursuant to the exercise of
outstanding Company Stock Rights and Warrants will be, when issued
in accordance with the terms thereof, duly authorized, validly
issued, fully paid and non-assessable. Except for issuances of
Shares pursuant to Company Stock Rights described in the first
sentence of Section 3.2(b) and Warrants described in
Section 3.2(c), since December 15, 2006, the Company has
not issued any Shares or designated or issued any shares of
Preferred Stock or Junior Preferred Stock. There are no bonds,
debentures, notes or other indebtedness having general voting
rights (or convertible into securities having such rights) (“
Voting Debt” ) of the Company or any Company
Subsidiary issued and outstanding. Except for the Company Rights
issuable pursuant to the Company Rights Agreement, the Company
Stock Rights described in the first sentence of Section 3.2(b)
and the Warrants described in Section 3.2(c), there are no
(x) options, warrants, calls, pre-emptive rights,
subscriptions or other rights, agreements, arrangements or
commitments of any kind, including any stockholder rights plan,
relating to the issued or unissued capital stock of the Company or
any Company Subsidiary, obligating the Company or any Company
Subsidiary to issue, transfer or sell or cause to be issued,
transferred or sold any shares of capital stock or Voting Debt of,
or other equity interest in, the Company or any Company Subsidiary
or securities convertible into or exchangeable for such shares or
equity interests, or obligating the Company or any Company
Subsidiary to grant, extend or enter into any such option, warrant,
call, subscription or other right, agreement, arrangement or
commitment (collectively, “ Equity Interests ”)
or (y) outstanding contractual obligations of the Company or
any Company Subsidiary to repurchase, redeem or otherwise acquire
any Shares or any capital stock of, or other Equity Interests in,
the Company or any Company Subsidiary or to provide funds to make
any investment (in the form of a loan, capital contribution or
otherwise) in the Company or any Company Subsidiary. No Company
Subsidicary owns any Shares.
(b) As of December 15, 2006,
the Company had outstanding Company Options to purchase 13,539,699
shares of Common Stock and no SARs for a maximum of 13,539,699
shares of Common Stock, no RSUs for a maximum of 0 shares of Common
Stock
20
and 11,461 shares of Restricted Stock granted
under Company Stock Plans. All of such Company Stock Rights and
Restricted Stock have been granted to service providers of the
Company and the Company Subsidiaries in the ordinary course of
business pursuant to the Company Stock Plans. Section 3.2(b)
of the Company Disclosure Schedule sets forth a listing of all
outstanding Company Stock Rights and shares of Restricted Stock as
of December 15, 2006 and (i) the date of their grant and
the portion of which that is vested as of December 15, 2006
and if applicable, the exercise price therefor, (ii) the date
upon which each Company Stock Right would normally be expected to
expire absent termination of employment or other acceleration, and
(iii) whether or not such Company Option is intended to
qualify as an “incentive stock option” within the
meaning of Section 422 of the Code.
(c) As of December 15, 2006,
the Company had outstanding Warrants to purchase 4,159,586 shares
of Common Stock at an exercise price of $5.00 per share and
Warrants to purchase 3,432,450 shares of Common Stock at an
exercise price of $9.50 per share. Section 3.2(c) of the
Company Disclosure Schedule sets forth a listing of all outstanding
Warrants as of December 15, 2006, their date of grant, their
expiration date and the exercise price therefore.
(d) There are no voting trusts or
other agreements to which the Company or any Company Subsidiary is
a party with respect to the voting of the Company’s Common
Stock or any capital stock of, or other equity interest of the
Company or any of the Company Subsidiaries. Neither the Company nor
any Company Subsidiary has granted any preemptive rights,
anti-dilutive rights or rights of first refusal or similar
rights.
Section 3.3 Authorization;
Validity of Agreement; Company Action . The Company has all
necessary corporate power and authority to execute and deliver this
Agreement, to perform its obligations hereunder and to consummate
the Transactions. The execution, delivery and performance by the
Company of this Agreement, and the consummation by it of the
Transactions, have been duly and validly authorized by the Company
Board of Directors and, no other corporate action on the part of
the Company is necessary to authorize the execution and delivery by
the Company of this Agreement and the consummation by it of the
Transactions, subject, in the case of the Merger, to the approval
of this Agreement by the holders of a majority of all of the Shares
entitled to be cast, if required by applicable law. This Agreement
has been duly executed and delivered by the Company and, assuming
due and valid authorization, execution and delivery hereof by
Parent and Purchaser, is a valid and binding obligation of the
Company enforceable against the Company in accordance with its
terms, except that (i) such enforcement may be subject to
applicable bankruptcy, insolvency or other similar laws, now or
hereafter in effect, affecting creditors’ rights generally
and (ii) the remedy of specific performance and injunctive and
other forms of equitable relief may be subject to equitable
defenses and to the discretion of the court before which any
proceeding therefor may be brought.
21
Section 3.4 Board Approvals .
The Company Board of Directors, at a meeting duly called and held,
has unanimously (i) determined that this Agreement, the Offer,
the Merger and other Transactions are advisable, fair to, and in
the best interests of the stockholders of the Company,
(ii) duly and validly approved and taken all corporate action
required to be taken by the Company Board of Directors to authorize
the consummation of the Transactions, (iii) approved this
Agreement and the transactions contemplated hereby (including the
Offer and the Merger) and the Support Agreements, which approval,
to the extent applicable, constituted approval under the provisions
of Section 203 of the DGCL as a result of which this Agreement
and the transactions contemplated hereby, including the Offer and
the Merger, as well as the Support Agreements and the transactions
contemplated thereby, are not and will not be subject to the
restrictions on “business combinations” under, the
provision of Section 203 of the DGCL; and
(iv) recommended that the stockholders of the Company accept
the Offer, tender their Shares to Purchaser pursuant to the Offer,
and adopt this Agreement. No further corporate action is required
by the Company Board of Directors, pursuant to the DGCL or
otherwise, in order for the Company to approve this Agreement, the
Support Agreements or the Transactions, including the Offer and the
Merger, subject, in the case of the Merger, to the approval of this
Agreement by the holders of a majority of the outstanding Shares,
if required by applicable law, as contemplated by Section 1.9,
which is the only stockholder vote that is required for adoption of
this Agreement and the consummation of the Merger by the
Company.
Section 3.5 Consents and
Approvals; No Violations . (a) None of the execution,
delivery or performance of this Agreement by the Company, the
acceptance for payment or acquisition of Shares pursuant to the
Offer, the consummation by the Company of the Merger or any other
Transaction or compliance by the Company with any of the provisions
of this Agreement will (i) conflict with or result in any
breach of any provision of the Company Governing Documents or the
organizational documents of any Company Subsidiary,
(ii) require any filing by the Company or any Company
Subsidiary, or the permit, authorization, consent or approval of,
any court, arbitral tribunal, administrative agency or commission
or other governmental or other regulatory authority or agency,
foreign, federal, state, local or supernational entity (a “
Governmental Entity ”) (except for (A) compliance
with any applicable requirements of the Exchange Act, (B) any
filings as may be required under the DGCL in connection with the
Merger, (C) filings, permits, authorizations, consents and
approvals as may be required under the Hart-Scott-Rodino Antitrust
Improvements Act of 1976, as amended (the “ HSR Act
”) and the Required Governmental Approvals, or (D) the
filing with the SEC and the Nasdaq of (1) the Schedule 14D-9,
(2) a Proxy Statement if stockholder approval of the Merger is
required by applicable law, (3) the information required by
Rule 14f-1 under the Exchange Act and (4) such reports under
Section 13(a) of the Exchange Act as may be required in
connection with this Agreement and the Offer and the Merger),
(iii) automatically result in a modification, violation or
breach of, or constitute (with or without notice or lapse of time
or both) a default (or give rise to any right, including, but not
limited to, any right of termination, amendment, cancellation or
acceleration) under, any of the terms, conditions or provisions of
any note, bond, mortgage, lien, indenture, lease, license, contract
or agreement, or other instrument or obligation to which the
Company or any Company Subsidiary is a party or by which any of
them or any of their respective properties or assets is bound (the
“ Company
22
Agreements ”) and which are set forth on the Company
Disclosure Schedule or should be so set forth (such Company
Agreements, the “ Company Scheduled Agreements
”) or (iv) violate any order, writ, injunction, decree,
statute, rule or regulation applicable to the Company, any Company
Subsidiary or any of their respective properties or assets; except
in the case of clauses (ii), (iii) or (iv) where
(x) any failure to obtain such permits, authorizations,
consents or approvals, (y) any failure to make such filings or
(z) any such modifications, violations, rights, breaches or
defaults have not had and would not reasonably be expected to have,
individually or in the aggregate, a Company Material Adverse Effect
or have a material adverse effect on the ability of the Company to
consummate the Offer, the Merger and the other
Transactions.
(b) The Company and the Company
Board of Directors have taken all action reasonably necessary to
(i) render the Company Rights inapplicable to this Agreement,
the Support Agreements, the Offer, the Merger and the other
Transactions and (ii) ensure that (A) neither Parent nor
any of its stockholders, affiliates or associates is or will become
an “Acquiring Person” (as defined in the Company Rights
Agreement) solely by reason of this Agreement, the Support
Agreements, the Offer, the Merger or any other Transaction,
(B) a “Distribution Date” (as defined in the
Company Rights Agreement) shall not occur solely by reason of this
Agreement, the Support Agreements, the Offer, the Merger or any
other Transaction and (C) the Company Rights shall expire at
the Effective Time.
Section 3.6 Company SEC Documents
and Financial Statements . (a) The Company and each of the
Company Subsidiaries has filed or furnished (as applicable) with
the SEC all forms, reports, schedules, statements and other
documents required by it to be filed or furnished (as applicable)
since and including September 30, 2002, under the Exchange Act
or the Securities Act of 1933, as amended (the “
Securities Act ”) (together with all certifications
required pursuant to the Sarbanes-Oxley Act of 2002 (the “
Sarbanes-Oxley Act ”)) (such documents and any other
documents filed by the Company and each Company Subsidiary with the
SEC, as have been amended since the time of their filing,
collectively, the “ Company SEC Documents ”). As
of their respective filing dates the Company SEC Documents
(i) did not (or with respect to Company SEC Documents filed
after the date hereof, will not) contain any untrue statement of a
material fact or omit to state a material fact required to be
stated therein or necessary in order to make the statements made
therein, in light of the circumstances under which they were made,
not misleading and (ii) complied in all material respects with
the applicable requirements of the Exchange Act or the Securities
Act, as the case may be, the Sarbanes-Oxley Act and the applicable
rules and regulations of the SEC thereunder. None of the Company
Subsidiaries is currently required to file any forms, reports or
other documents with the SEC. All of the audited consolidated
financial statements and unaudited consolidated interim financial
statements of the Company and its consolidated Subsidiaries
included in the Company SEC Documents (collectively, the “
Financial Statements ”), (A) have been or will
be, as the case may be, prepared from, are in accordance with, and
accurately reflect the books and records of the Company and its
consolidated Subsidiaries in all material respects, (B) have
been or will be, as the case may be, prepared in accordance with
United States generally accepted accounting principles (“
GAAP ”) applied on a consistent basis
23
during the periods involved (except as may be
indicated in the notes thereto or, in the case of interim financial
statements, for normal and recurring year-end adjustments and as
may be permitted by the SEC on Form 10-Q, 8-K or any successor or
like form under the Exchange Act) and (C) fairly present in
all material respects the consolidated financial position and the
consolidated results of operations and cash flows of the Company
and its consolidated Subsidiaries as of the times and for the
periods referred to therein.
(b) Without limiting the generality
of Section 3.6(a), (i) PricewaterhouseCoopers LLP has not
resigned or been dismissed as independent public accountant of the
Company as a result of or in connection with any disagreement with
the Company on a matter of accounting principles or practices,
financial statement disclosure or auditing scope or procedure,
(ii) no executive officer of the Company has failed in any
respect to make, without qualification, the certifications required
of him or her under Section 302 or 906 of the Sarbanes-Oxley
Act with respect to any form, report or schedule filed by the
Company with the SEC since the enactment of the Sarbanes-Oxley Act
and (iii) no enforcement action has been initiated or, to the
knowledge of the Company, threatened against the Company by the SEC
relating to disclosures contained in any Company SEC
Document.
Section 3.7 Internal Controls;
Sarbanes-Oxley Act . (a) The Company and the Company
Subsidiaries have designed and maintained a system of internal
controls over financial reporting (as defined in Rules 13a-15(f)
and 15d-15(f) of the Exchange Act) sufficient to provide reasonable
assurances regarding the reliability of financial reporting. The
Company (i) has designed and maintains disclosure controls and
procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the
Exchange Act) to ensure that material information required to be
disclosed by the Company in the reports that it files or submits
under the Exchange Act is recorded, processed, summarized and
reported within the time periods specified in the SEC’s rules
and forms and is accumulated and communicated to the
Company’s management as appropriate to allow timely decisions
regarding required disclosure and (ii) has disclosed to the
Company’s auditors and the audit committee of the Company
Board of Directors (and made summaries of such disclosures
available to Parent) (A) any significant deficiencies and
material weaknesses in the design or operation of internal controls
over financial reporting that are reasonably likely to adversely
affect in any material respect the Company’s ability to
record, process, summarize and report financial information and
(B) any fraud, whether or not material, that involves
management or other employees who have a significant role in the
Company’s internal controls over financial reporting. The
Company is in compliance in all material respects with all
effective provisions of the Sarbanes-Oxley Act.
(b) Neither the Company nor any of
its Subsidiaries nor, to the Company’s knowledge, any
director, officer, auditor, accountant or representative of the
Company or any of its Subsidiaries has received or otherwise had or
obtained knowledge of any substantive complaint, allegation,
assertion or claim, whether written or oral, that the Company or
any of its Subsidiaries has engaged in questionable accounting or
auditing practices. No current or former attorney representing the
Company or any of its Subsidiaries has reported evidence of a
material violation of securities laws, breach of fiduciary duty or
similar violation by the Company or any of its officers, directors,
employees or agents to the current Company Board or any committee
thereof or to any current director or executive officer of the
Company.
24
(c) To the Company’s
knowledge, no employee of the Company or any of its Subsidiaries
has provided or is providing information to any law enforcement
agency regarding the commission or possible commission of any crime
or the violation or possible violation of any applicable legal
requirements of the type described in Section 806 of the
Sarbanes-Oxley Act by the Company or any of its Subsidiaries.
Neither the Company nor any of its Subsidiaries nor, to the
knowledge of the Company, any director, officer, employee,
contractor, subcontractor or agent of the Company or any such
Subsidiary has discharged, demoted, suspended, threatened, harassed
or in any other manner discriminated against an employee of the
Company or any of its Subsidiaries in the terms and conditions of
employment because of any lawful act of such employee described in
Section 806 of the Sarbanes-Oxley Act.
Section 3.8 Absence of Certain
Changes . (a) Except as contemplated by this Agreement or
in the Company SEC Documents filed prior to the date hereof, since
December 31, 2005 (the “ Balance Sheet Date
”), each of the Company and each Company Subsidiary has
conducted its respective business in the ordinary course of
business consistent with past practice.
(b) From the Balance Sheet Date
through the date of this Agreement, no fact(s), change(s),
event(s), development(s) or circumstances have occurred, arisen,
come into existence or become known, which have had or would
reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect, and (ii) no action has been
taken by the Company or any Company Subsidiary that, if taken
during the period from the date of this Agreement through the
Effective Time, would constitute a breach of the following
subsections of Section 5.1: (a) (b), (c), (d), (i), (m),
(p), (q), (s), (t) and (u).
Section 3.9 No Undisclosed
Liabilities . Except (a) as reflected or otherwise
reserved against on the Financial Statements, (b) for
liabilities and obligations incurred since September 30, 2006
in the ordinary course of business, (c) for liabilities and
obligations incurred under this Agreement or in connection with the
Transactions and (d) for liabilities and obligations incurred
under any Company Agreement other than liabilities or obligations
due to breaches thereunder, neither the Company nor any Company
Subsidiary has incurred any liabilities or obligations of any
nature, whether or not accrued, contingent or otherwise required by
GAAP to be recognized or disclosed on a consolidated balance sheet
of the Company or any Company Subsidiary or in the notes
thereto.
Section 3.10 Litigation . As
of the date hereof, there is no claim, action, suit, arbitration,
investigation, alternative dispute resolution action or any other
judicial or administrative proceeding, in law or equity
(collectively, a “ Legal Proceeding ”), pending
against (or, to the Company’s knowledge, threatened against
or naming as a party thereto), the Company or any Company
Subsidiary or to the Company’s knowledge, any executive
officer or director of the Company or any Company Subsidiary (in
their capacity as
25
such). None of the Company or any Company
Subsidiary is subject to any outstanding order, writ, injunction,
decree or arbitration ruling or judgment of a Governmental Entity
which has had or would reasonably be expected to have, individually
or in the aggregate, a Company Material Adverse Effect or prevent
or materially delay the consummation of the Offer, the Merger or
any of the other Transactions.
Section 3.11 Employee Benefit
Plans; ERISA .
(a) Section 3.11(a) of the
Company Disclosure Schedule sets forth a correct and complete list
of all material employee benefit plans, programs, agreements or
arrangements, including pension, retirement, profit sharing,
deferred compensation, stock option, change in control, retention,
equity or equity-based compensation, stock purchase, employee stock
ownership, severance pay, vacation, bonus or other incentive plans,
all medical, vision, dental or other health plans, all life
insurance plans, and all other employee benefit plans or fringe
benefit plans, including “employee benefit plans” as
that term is defined in Section 3(3) of ERISA, in each case,
whether oral or written, funded or unfunded, or insured or
self-insured, maintained by the Company or any Company Subsidiary,
or to which the Company or any Company Subsidiary contributes or is
obligated to contribute thereunder, or with respect to which the
Company or any Company Subsidiary has or may have any liability
(contingent or otherwise), in each case, for or to (i) any
current or former employees, directors or officers of the Company
or any Company Subsidiary located primarily in the United States
and/or their dependents (collectively, the “Benefit
Plans”), or (ii) any current or former employees,
directors or officers of the Company or any Company Subsidiary not
located primarily in the United States and/or their dependents
(collectively, the “Foreign Plans”). For purposes of
this Agreement, the term “plan,” when used with respect
to Foreign Plans, shall mean a “scheme” or other
employee benefit program or arrangement in accordance with specific
country usage.
(b) All Benefit Plans that are
intended to be subject to Code Section 401(a) and any trust
agreement that is intended to be tax exempt under Code
Section 501(a) have been determined by the Internal Revenue
Service to be qualified under Code Section 401(a) and exempt
from taxation under Code Section 501(a), and, to the knowledge
of the Company, nothing has occurred that would adversely affect
the qualification of any such plan. Except as has not had and would
not reasonably be expected to have, individually or in the
aggregate, a Company Material Adverse Effect: (i) each
Benefit Plan and any related trust subject to ERISA complies in all
material respects with and has been administered in substantial
compliance with, (A) the provisions of ERISA, (B) all
provisions of the Code, (C) all other applicable laws, and
(D) its terms and the terms of any collective bargaining or
collective labor agreements; (ii) neither the Company nor any
Company Subsidiary has received any written notice from any
Governmental Entity questioning or challenging such compliance;
(iii) there are no unresolved claims or disputes under the
terms of, or in connection with, the Benefit Plans other than
claims for benefits which are payable in the ordinary course;
(iv) there has not been any non-exempt “prohibited
transaction” (within the meaning of Section 406 of ERISA
or Section 4975 of the Code) with respect to any Benefit Plan;
(v) no
26
litigation has been commenced with respect to
any Benefit Plan and, to the knowledge of the Company, no such
litigation is threatened (other than routine claims for benefits in
the normal course); (vi) there are no governmental audits or
investigations pending or, to the knowledge of the Company,
threatened in connection with any Benefit Plan; and (vii) to
the knowledge of the Company, there are not any facts that could
give rise to any liability in the event of any governmental audit
or investigation.
(c) Neither the Company nor any
ERISA Affiliate of the Company (as defined below) (i) has an
“obligation to contribute” (as defined in ERISA
Section 4212) to a Benefit Plan that is a “multiemployer
plan” (as defined in ERISA Sections 4001(a)(3) and 3(37)(A));
(ii) sponsors, maintains or contributes to any plan, program
or arrangement that provides for post-retirement or other
post-employment welfare benefits (other than health care
continuation coverage as required by applicable law); and (iii )
sponsors a Foreign Plan that is a defined benefit pension plan
intended to be registered or approved by any Governmental
Entity.
(d) Neither the Company nor any
ERISA Affiliate has ever maintained, established, sponsored,
participated in, or contributed to, any defined benefit plan (as
defined in ERISA Section 3(35)) subject to Part 3 of Subtitle
B of Title I of ERISA, Title IV of ERISA or Section 412 of the
Code.
(e) Except as has not had and would
not reasonably be expected to have, individually or in the
aggregate, a Company Material Adverse Effect, (i) each Foreign
Plan complies in all material respects with and has been
administered in substantial compliance with the laws of the
applicable foreign country, (ii) each Foreign Plan which,
under the laws of the applicable foreign country, is required to be
registered or approved by any Governmental Entity, has been so
registered or approved, (iii) all contributions to each
Foreign Plan required to be made by the Company or the Company
Subsidiaries through the Closing Date have been or shall be made
or, if applicable, shall be accrued in accordance with
country-specific accounting practices, (iv) no litigation has
been commenced with respect to any Foreign Plan and, to the
knowledge of the Company, no such litigation is threatened (other
than routine claims for benefits in the normal course),
(v) there are no governmental audits or investigations pending
or, to the knowledge of the Company, threatened in connection with
any Foreign Plan and (vi) no condition exists that would
prevent the Company or a Company Subsidiary from terminating or
amending any Foreign Plan at any time for any reason.
(f) Except as has not had and would
not reasonably be expected to have, individually or in the
aggregate, a Company Material Adverse Effect, all reports, returns
and similar documents with respect to all Benefit Plans or Foreign
Plans required to be filed by the Company or any Company Subsidiary
with any Governmental Entity or distributed to any Benefit Plan or
Foreign Plan participant have been duly and timely filed or
distributed.
(g) Section 3.11(g) of the
Company Disclosure Schedule discloses each Benefit Plan that is an
employee welfare benefit plan which is (i) unfunded or
self-insured or (ii) funded through a “welfare benefit
fund”, as such term is defined in Code
Section 419(e)
27
or other funding mechanism. Except as has not
had and would not reasonably be expected to have, individually or
in the aggregate, a Company Material Adverse Effect, each such
employee welfare benefit plan may be amended or terminated
(including with respect to benefits provided to retirees and other
former employees) without liability (other than benefits then
payable under such plan without regard to such amendment or
termination) to the Company or any Company Subsidiary at any time.
Each of the Company and the Company Subsidiaries complies in all
material respects with the applicable requirements of
Section 4980B(f) of the Code or any similar state statute with
respect to each Benefit Plan that is a group health plan within the
meaning of Section 5000(b)(1) of the Code or such state
statute. Neither the Company nor any Company Subsidiary has any
material obligations for retiree health or life insurance benefits
under any Benefit Plan (other than for continuation coverage under
Section 4980B(f) of the Code).
(h) Except as may be required by
applicable law, or as contemplated under this Agreement, neither
the Company nor any Company Subsidiary has any plan or commitment
to create any additional Benefit Plans or Foreign Plans, or to
amend or modify any existing Benefit Plan or Foreign Plan in such a
manner as to materially increase the cost of such Benefit Plan or
Foreign Plan to the Company or any Company Subsidiary.
(i) Section 3.11(i) of the
Company Disclosure Schedule discloses: (i) each material
payment (including any bonus, severance, unemployment compensation,
deferred compensation, forgiveness of indebtedness or golden
parachute payment) becoming due to any current or former employee
under any Benefit Plan or Foreign Plan because of this Agreement
(or the consummation of the Transactions); (ii) any increase
in any material respect of any benefit otherwise payable under any
Benefit Plan or Foreign Plan; (iii) any acceleration in any
material respect of the time of payment or vesting of any such
benefits under any Benefit Plan or Foreign Plan; or (iv) any
material obligation to fund any trust or other arrangement with
respect to compensation or benefits under a Benefit Plan or Foreign
Plan in each case caused or triggered by the execution and delivery
of this Agreement or the consummation of the Offer or the Merger or
the other Transactions contemplated hereby. No payment or benefit
which has been, will or may be made by the Company or any Company
Subsidiary with respect to any current or former employee located
in the United States in connection with the execution and delivery
of this Agreement or the consummation of the Transactions
contemplated hereby would fail to be deductible under
Section 162(m) of the Code. Neither this Agreement (or the
consummation of the Transactions contemplated hereby) nor any other
agreement, plan, arrangement or other contract between the Company
or any Company Subsidiary and an employee or other service provider
that, considered individually or considered collectively with any
other such agreements, plans, arrangements or other contracts,
could reasonably be expected to, give rise directly or indirectly
to the payment of any amount that would be characterized as an
“excess parachute payment” within the meaning of
Section 280G(b)(1) of the Code.
28
(j) Correct and complete copies have
been delivered or made available to Parent by the Company of all
material Benefit Plans and Foreign Plans (including all amendments
and attachments thereto); written summaries of any material Benefit
Plan not in writing, all related trust documents; all insurance
contracts or other funding arrangements to the degree applicable;
the most recent annual information filings (Form 5500) and annual
financial reports for those Benefit Plans (where required); the
most recent determination letter from the Internal Revenue Service
(where required); all material written agreements and contracts
relating to each Benefit Plan and Foreign Plan, including
administrative service agreements and group insurance contracts;
and the most recent summary plan descriptions for the Benefit Plans
(where required) and in respect of Benefit Plans and Foreign Plans,
the most recent actuarial valuation and any subsequent valuation or
funding advice (where required, including draft
valuations).
(k) Neither the Company nor any
Subsidiary has entered into any contract, agreement, arrangement or
understanding with any officer or director of the Company or any
Company Subsidiary in connection with or in contemplation of the
Transactions, except as contemplated by this Agreement or the
Transactions.
(l) To the knowledge of the Company,
no payment pursuant to any Benefit Plans or other arrangement
between the Company or a Company Subsidiary and any “service
provider” (as such term is defined in Section 409A of
the Code and the United States Treasury Regulations and IRS
guidance thereunder), including, without limitation, the grant,
vesting or exercise of any stock option or the grant or vesting of
an RSU, would subject any Person to a tax pursuant to
Section 409A of the Code, whether pursuant to the consummation
of the Offer or the Merger, any other transactions contemplated by
this Agreement or otherwise.
(m) All Company Options have been
appropriately authorized by the Company’s Board of Directors
or an appropriate committee thereof, including approval of the
option exercise price or the methodology for determining the option
exercise price and the substantive option terms. All Company
Options granted to employees in the United States that are
potentially subject to Code Section 409A have a per share
exercise price which reflects the fair market value of the
Company’s common stock as determined in good faith compliance
with Section 409A of the Code on the date that the option was
granted (within the meaning of United States Treasury Regulation
§1.421-1(c)). To the knowledge of the Company, no Company
Options have been retroactively granted, or the exercise price of
any Company Option determined retroactively. The Company Board of
Directors, at a meeting duly called and held, has determined that
each of the members of the Compensation Committee of the Company
Board of Directors (the “ Compensation Committee
”) are, and the Company represents and warrants that each of
the members of the Compensation Committee are and at the Expiration
Date will be, “independent directors” as defined in
Rule 4200(a)(15) of the Nasdaq Marketplace Rules and eligible to
serve on the Compensation Committee under the Exchange Act and all
applicable Nasdaq Marketplace Rules. On or prior to the date
hereof, the Compensation Committee, at a meeting duly called and
held, approved each Company Compensation Arrangement as an
“employment compensation, severance or other employee benefit
arrangement” within the meaning of Rule 14d-10(d)(1) under
the Exchange Act (an “ Employment Compensation
Arrangement ”), and has taken all other action necessary
to satisfy the requirements of the non-exclusive safe-harbor with
respect to such Company Compensation Arrangements in accordance to
Rule 14d-10(d)(2) under the Exchange Act.
29
Section 3.12 Taxes
.
(a) The Company and each Company
Subsidiary has timely filed with the appropriate Governmental
Entity all material Tax Returns required to be filed by them. All
such Tax Returns are complete and accurate in all material
respects. All material Taxes due and owing by any of the Company
and each Company Subsidiary on or before the date hereof (whether
or not shown on any Tax Returns) have been paid, or both are being
contested in good faith and have been reserved for in accordance
with GAAP on the Financial Statements. None of the Company or any
Company Subsidiary currently is the beneficiary of any extension of
time within which to file any material Tax Return. No claim has
ever been made by a Tax authority in a jurisdiction where any of
the Company or any Company Subsidiary does not file Tax Returns
that it is or may be subject to taxation by that
jurisdiction.
(b) The unpaid Taxes of the Company
and each Company Subsidiary did not, as of the dates of the
Financial Statements, exceed the reserve for Tax liability set
forth on the face of the balance sheets contained in such Financial
Statements. Since th